197 related articles for article (PubMed ID: 32408169)
41. Quinidine in the treatment of KCNT1-positive epilepsies.
Mikati MA; Jiang YH; Carboni M; Shashi V; Petrovski S; Spillmann R; Milligan CJ; Li M; Grefe A; McConkie A; Berkovic S; Scheffer I; Mullen S; Bonner M; Petrou S; Goldstein D
Ann Neurol; 2015 Dec; 78(6):995-9. PubMed ID: 26369628
[TBL] [Abstract][Full Text] [Related]
42. Quinidine therapy and therapeutic drug monitoring in four patients with KCNT1 mutations.
Yoshitomi S; Takahashi Y; Yamaguchi T; Oboshi T; Horino A; Ikeda H; Imai K; Okanishi T; Nakashima M; Saitsu H; Matsumoto N; Yoshimoto J; Fujita T; Ishii A; Hirose S; Inoue Y
Epileptic Disord; 2019 Feb; 21(1):48-54. PubMed ID: 30782581
[TBL] [Abstract][Full Text] [Related]
43. Potassium channelopathies associated with epilepsy-related syndromes and directions for therapeutic intervention.
Gribkoff VK; Winquist RJ
Biochem Pharmacol; 2023 Feb; 208():115413. PubMed ID: 36646291
[TBL] [Abstract][Full Text] [Related]
44. The binding site for channel blockers that rescue misprocessed human long QT syndrome type 2 ether-a-gogo-related gene (HERG) mutations.
Ficker E; Obejero-Paz CA; Zhao S; Brown AM
J Biol Chem; 2002 Feb; 277(7):4989-98. PubMed ID: 11741928
[TBL] [Abstract][Full Text] [Related]
45. A quinidine non responsive novel KCNT1 mutation in an Indian infant with epilepsy of infancy with migrating focal seizures.
Madaan P; Jauhari P; Gupta A; Chakrabarty B; Gulati S
Brain Dev; 2018 Mar; 40(3):229-232. PubMed ID: 29037447
[TBL] [Abstract][Full Text] [Related]
46. Cardiac metabolic effects of K
Smith CO; Wang YT; Nadtochiy SM; Miller JH; Jonas EA; Dirksen RT; Nehrke K; Brookes PS
FASEB J; 2018 Jun; 32(11):fj201800139R. PubMed ID: 29863912
[TBL] [Abstract][Full Text] [Related]
47. [Genetic and clinical analysis of children with early-onset epilepsy encephalopathy caused by KCNT1 gene mutation].
Chen Y; Bao XH; Zhang QP; Wang JP; Wen YX; Yu SJ; Zhao Y
Zhonghua Er Ke Za Zhi; 2018 Nov; 56(11):824-828. PubMed ID: 30392206
[No Abstract] [Full Text] [Related]
48. Modulation of HERG potassium channels by extracellular magnesium and quinidine.
Po SS; Wang DW; Yang IC; Johnson JP; Nie L; Bennett PB
J Cardiovasc Pharmacol; 1999 Feb; 33(2):181-5. PubMed ID: 10028924
[TBL] [Abstract][Full Text] [Related]
49. Characterisation of recombinant HERG K+ channel blockade by the Class Ia antiarrhythmic drug procainamide.
Ridley JM; Milnes JT; Benest AV; Masters JD; Witchel HJ; Hancox JC
Biochem Biophys Res Commun; 2003 Jun; 306(2):388-93. PubMed ID: 12804575
[TBL] [Abstract][Full Text] [Related]
50. KCNT1-related epilepsy: An international multicenter cohort of 27 pediatric cases.
Borlot F; Abushama A; Morrison-Levy N; Jain P; Puthenveettil Vinayan K; Abukhalid M; Aldhalaan HM; Almuzaini HS; Gulati S; Hershkovitz T; Konanki R; Lingappa L; Luat AF; Shafi S; Tabarki B; Thomas M; Yoganathan S; Alfadhel M; Arya R; Donner EJ; Ehaideb SN; Gowda VK; Jain V; Madaan P; Myers KA; Otsubo H; Panda P; Sahu JK; Sampaio LPB; Sharma S; Simard-Tremblay E; Zak M; Whitney R
Epilepsia; 2020 Apr; 61(4):679-692. PubMed ID: 32167590
[TBL] [Abstract][Full Text] [Related]
51. Structural implications of hERG K
Helliwell MV; Zhang Y; El Harchi A; Du C; Hancox JC; Dempsey CE
J Biol Chem; 2018 May; 293(18):7040-7057. PubMed ID: 29545312
[TBL] [Abstract][Full Text] [Related]
52. Inhibition of the current of heterologously expressed HERG potassium channels by flecainide and comparison with quinidine, propafenone and lignocaine.
Paul AA; Witchel HJ; Hancox JC
Br J Pharmacol; 2002 Jul; 136(5):717-29. PubMed ID: 12086981
[TBL] [Abstract][Full Text] [Related]
53. Identification of quaternary ammonium compounds as potent inhibitors of hERG potassium channels.
Xia M; Shahane SA; Huang R; Titus SA; Shum E; Zhao Y; Southall N; Zheng W; Witt KL; Tice RR; Austin CP
Toxicol Appl Pharmacol; 2011 May; 252(3):250-8. PubMed ID: 21362439
[TBL] [Abstract][Full Text] [Related]
54. A recurrent KCNT1 mutation in two sporadic cases with malignant migrating partial seizures in infancy.
Ishii A; Shioda M; Okumura A; Kidokoro H; Sakauchi M; Shimada S; Shimizu T; Osawa M; Hirose S; Yamamoto T
Gene; 2013 Dec; 531(2):467-71. PubMed ID: 24029078
[TBL] [Abstract][Full Text] [Related]
55. Case Report of Novel Genetic Variant in KCNT1 Channel and Pharmacological Treatment With Quinidine. Precision Medicine in Refractory Epilepsy.
Kravetz MC; Viola MS; Prenz J; Curi M; Bramuglia GF; Tenembaum S
Front Pharmacol; 2021; 12():648519. PubMed ID: 34122071
[No Abstract] [Full Text] [Related]
56. Therapeutic Drug Monitoring of Quinidine in Pediatric Patients with
Ferretti A; Simeoli R; Cairoli S; Pietrafusa N; Trivisano M; Dionisi Vici C; Specchio N; Goffredo BM
Pharmaceutics; 2022 Oct; 14(10):. PubMed ID: 36297665
[TBL] [Abstract][Full Text] [Related]
57. Treatment Responsiveness in KCNT1-Related Epilepsy.
Fitzgerald MP; Fiannacca M; Smith DM; Gertler TS; Gunning B; Syrbe S; Verbeek N; Stamberger H; Weckhuysen S; Ceulemans B; Schoonjans AS; Rossi M; Demarquay G; Lesca G; Olofsson K; Koolen DA; Hornemann F; Baulac S; Rubboli G; Minks KQ; Lee B; Helbig I; Dlugos D; Møller RS; Bearden D
Neurotherapeutics; 2019 Jul; 16(3):848-857. PubMed ID: 31054119
[TBL] [Abstract][Full Text] [Related]
58. Targeted treatment of migrating partial seizures of infancy with quinidine.
Bearden D; Strong A; Ehnot J; DiGiovine M; Dlugos D; Goldberg EM
Ann Neurol; 2014 Sep; 76(3):457-61. PubMed ID: 25042079
[TBL] [Abstract][Full Text] [Related]
59. Drosophila expressing mutant human KCNT1 transgenes make an effective tool for targeted drug screening in a whole animal model of KCNT1-epilepsy.
Hussain R; Lim CX; Shaukat Z; Islam A; Caseley EA; Lippiat JD; Rychkov GY; Ricos MG; Dibbens LM
Sci Rep; 2024 Feb; 14(1):3357. PubMed ID: 38336906
[TBL] [Abstract][Full Text] [Related]
60. Quinazolinone dimers as a potential new class of safer Kv1 inhibitors: Overcoming hERG, sodium and calcium channel affinities.
Emam AM; Peigneur S; Depuydt AS; Ibrahim SM; Lopes Pinheiro-Junior E; El-Sadek M; Hendrickx L; Tytgat J; Kothayer H
Bioorg Chem; 2021 Oct; 115():105264. PubMed ID: 34416509
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
